Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 601 - 608 of 11439 results
Doing Well to Do Good
December 21, 2023| Article| Viewpoint
Court Vacates SEC’s New Share Repurchase Disclosure Rules
December 21, 2023| Advisory| Viewpoint
HHS Pushes Back on Accumulator Ruling, Prompting Wait-and-See Situation
December 21, 2023| News
Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting
December 21, 2023| Blog| Viewpoint
Doing Well to Do Good
December 21, 2023| Article| Viewpoint
Chicago Employers Must Now Provide Sick Leave and PTO to Employees
December 21, 2023| Blog| Viewpoint
2023: Another Year Chock Full of Challenges for FDA
December 20, 2023| Blog| Viewpoint
Carveouts, Add-ons Key As PE Firms Strategize For 2024
December 19, 2023| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.